Skip to main content Back to Top

10/1/2002
Press Release

ASHP, CPNP Program Approved to Recertify Specialists in Psychiatric Pharmacy

Board-Certified Psychiatric Pharmacists (BCPP) will be eligible to maintain their status after completing a professional development program created by the American Society of Health-System Pharmacists (ASHP) and the College of Psychiatric and Neurologic Pharmacists (CPNP).

The recertification program approved this month by the Board of Pharmaceutical Specialties (BPS) is an adaptation of ASHP’s well-received review course for the BPS certification examination along with specifically designed educational segments of the CPNP annual meeting. BPS requires its board-certified specialists to recertify every seven years using either a multiple-choice examination or a professional development program.  The first group of BCPP is scheduled to recertify at the end of 2003.

CPNP’s recertification curriculum will be offered at the CPNP Annual Meeting May 1-4, 2003, in Charleston, S.C. The five hours of live programming will be offered on Sunday, May 4 from 8:00 a.m.-1:00 p.m. and will provide coverage of the Domain I topics as defined in the BPS Candidate Guide for BCPPs. Different topics from Domain I will be featured at the CPNP Annual Meetings held each spring.

The curriculum for the ASHP review course is based on case studies and includes updates on disease states and therapies, pharmacology, and statistics related to psychiatric pharmacy.  The course will be offered immediately following the 2003 CPNP Annual Meeting, May 4-6, 2003, in Charleston, S.C. A home study program will complement the live program and an exam covering the course contents and home study program must be completed by each recertification candidate. The course will also be available on CD-ROM. A portion of the educational programming at the CPNP annual meeting will focus on subspecialty areas and recent advances in psychiatric pharmacy in order to provide the full spectrum of current information for the psychiatric pharmacy specialist. Participants will be able to tailor the meeting content to meet their individual needs.

Combined, the programs will offer approximately 35 contact hours of continuing education annually. The Board of Pharmaceutical Specialties will release specific details in the coming weeks on the amount of recertification credit required for board-certified specialists in psychiatric pharmacy whose seven year cycle ends in the next five to seven years.

“We are thrilled to be able to continue providing resources to psychiatric pharmacists and to work in conjunction with CPNP,” said ASHP President Debra S. Devereaux, M.B.A., FASHP. “This partnership will offer BCPPs with a thorough review of the cutting-edge information they need to provide patients with high-quality care.”

“CPNP is delighted to work with ASHP to bring this important recertification process to all board-certified specialists in psychiatric pharmacy,” commented CPNP President Stanley S. Weber, Pharm.D, FASHP, BCPP. “This mechanism will help ensure that pharmacists who provide services within the mental health and neurologic communities stay demonstrably up-to-date.”

CPNP is a 475-member professional association that represents pharmacists, practitioners, educators, scientists, administrators, residents/fellows and students involved in the pharmaceutical care of psychiatric and/or neurologic patients. CPNP’s mission is to promote excellence in pharmacy practice, education and research to optimize the treatment of individuals affected by psychiatric and neurologic disorders. To accomplish this mission, CPNP facilitates the exchange of information through a member email exchange, an organizational newsletter and an annual educational meeting. Additional information on CPNP and its services can be found at www.cpnp.org.

ASHP is the 30,000-member national professional association that represents pharmacists who practice in hospitals, health maintenance organizations, long-term care facilities, home care, and other components of health care systems. ASHP, which has a long history of medication-error prevention efforts, believes that the mission of pharmacists is to help people make the best use of medicines. Assisting pharmacists in fulfilling this mission is ASHP's primary objective. The Society has extensive publishing and educational programs designed to help members improve their professional practice, and it is the national accrediting organization for pharmacy residency and pharmacy technician training programs. For more information, visit www.ashp.org or www.safemedication.com.